abstract |
CRYSTALLIZATION METHOD AND BIOAVAILABILITY The disclosure relates to preparation, in-vitro and in vivo characterization of novel forms of (1 -hydroxy-2-imidazol- 1-yl-1 -phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans. |